Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride MeSH Descriptor Data 2026


MeSH Heading
trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride
Tree Number(s)
D02.455.426.392.368.367.900
Unique ID
D001371
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D001371
Scope Note
An anti-cholesteremic agent that inhibits delta 7-reductase, delta 14 reductase, and sterol biosynthesis.
Entry Term(s)
AY-9944
AY9944
AY9944 A-7
AY9944-A-7
Pharm Action
Anticholesteremic Agents
Enzyme Inhibitors
Registry Numbers
366-93-8
0
CAS Type 1 Name
1,4-Cyclohexanedimethanamine, N,N'-bis((2-chlorophenyl)methyl)-, dihydrochloride, trans-
Previous Indexing
Benzyl Compounds (1972-1974)
Cyclohexanes (1968-1974)
Methylamines (1972-1974)
Public MeSH Note
2005; see AY-9944 1991-2004; see CYCLOHEXANES 1975-1990
History Note
2005(1975)
Date Introduced
1991/01/01
Last Updated
2015/11/24
trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride Preferred
AY-9944 Narrower
page delivered in 0.152s